LoadingLoading
  • Browse By Category

  • Products
  • Services
  • Support
  • Corporate
  • Back
  • Products

  • Antibodies
  • Instruments
  • Research Kits
  • Proteins & Enzymes
  • Peptides
  • COVID-19 Assays
  • Back
  • Antibodies

  • Primary Antibodies
  • Secondary Antibodies
  • Tag Antibodies
  • Antibody Panel Packs
  • Back
  • Primary Antibodies

  • DNA Methylation Antibodies
  • Cell Structure & Function Antibodies
  • RNA Processing & Modification Antibodies
  • Chromatin & Transcription Antibodies
  • Other Primary Antibodies
  • Histone Modification Antibodies
  • Signal Transduction Antibodies
  • Metabolism Antibodies
  • Immunology & Inflammation Antibodies
  • Back
  • Cell Structure & Function Antibodies

  • DNA Damage & Repair Antibodies
  • Apoptosis & Cell Death Antibodies
  • Cell Cycle Antibodies
  • Cellular Structure Antibodies
  • Trafficking Antibodies
  • Back
  • Chromatin & Transcription Antibodies

  • DNA Replication & Transcription Antibodies
  • Chromatin Remodeling Antibodies
  • Cell Growth Antibodies
  • Development & Differentiation Antibodies
  • Back
  • Histone Modification Antibodies

  • Histone Methylation (Lysine) Antibodies
  • Histone Acetylation Antibodies
  • Histone Phosphorylation Antibodies
  • Ubiquitination & SUMOylation Antibodies
  • Histone Methylation (Arginine) Antibodies
  • Other Histone Methylation Antibodies
  • Other Histone Acetylation Antibodies
  • Histone Deacetylation Antibodies
  • Other Histone Antibodies
  • Back
  • Signal Transduction Antibodies

  • Cell Surface Receptor & Kinase Antibodies
  • Intracellular Kinase & Adaptor Protein Antibodies
  • Phosphatase Antibodies
  • Secreted Growth Factor Antibodies
  • Back
  • Metabolism Antibodies

  • Glucose Metabolism Antibodies
  • Lipid Metabolism Antibodies
  • Protein Metabolism Antibodies
  • Nucleotide Metabolism Antibodies
  • Back
  • Immunology & Inflammation Antibodies

  • Cell Marker & Receptor Antibodies
  • Cytokine Antibodies
  • Other Immunology Antibodies
  • Back
  • Antibody Panel Packs

  • Histone Modification
  • DNA Methylation
  • Back
  • Instruments

  • Sonication Devices
  • Magnets & Sample Mixers
  • Back
  • Research Kits

  • DNA Methylation
  • Chromatin & Transcription
  • Histone Methylation
  • Acetylation & Deacetylation
  • Gene Editing & Silencing
  • Sample Preparation
  • DNA Damage & Repair
  • Next Generation Sequencing
  • RNA Methylation
  • Other Histone Modifications
  • Back
  • DNA Methylation

  • DNA Bisulfite Conversion
  • DNA Methylation Quantification
  • DNA Methyltransferase & Demethylase Assays
  • Methylated DNA Immunoprecipitation
  • Methylated DNA Amplification
  • Back
  • Chromatin & Transcription

  • General Chromatin Immunoprecipitation
  • In Vitro Protein-DNA Interaction
  • Methyl-Histone Chromatin IP
  • Acetyl-Histone Chromatin IP
  • Methyl-DNA Binding Protein ChIP
  • Chromatin Analysis
  • Back
  • Histone Methylation

  • Histone Methyltransferase Assay
  • Histone Methylation Quantification
  • Histone Demethylase Assay
  • Back
  • Acetylation & Deacetylation

  • Histone Acetyltransferase (HAT) Assay
  • Histone Deacetylase (HDAC) Assay
  • Histone Acetylation Quantification
  • Back
  • Sample Preparation

  • DNA Preparation
  • Protein Preparation
  • Chromatin Preparation
  • RNA Preparation
  • Back
  • Other Histone Modifications

  • Sumoylation
  • Histone Phosphorylation Assay
  • Histone Citrullination
  • Back
  • Proteins & Enzymes

  • DNA Methylation/Demethylation Proteins
  • Methylated DNA Binding Proteins
  • Unmodified Histone Proteins
  • Chromatin Binding/Transcription Proteins
  • ADP Ribose Proteins
  • DNA Damage & Repair Proteins
  • Modified Histone Proteins
  • Back
  • DNA Methylation/Demethylation Proteins

  • DNA Demethylation Proteins
  • DNA Methylation Proteins
  • Back
  • Modified Histone Proteins

  • Histone Methylation Proteins
  • Histone Demethylation Proteins
  • Histone Acetylation Proteins
  • Histone Deacetylation Proteins
  • Histone Phosphorylation Proteins
  • Histone Sumoylation Proteins
  • Back
  • Peptides

  • Histone Methylation Peptides
  • Histone Acetylation Peptides
  • Histone Phosphorylation Peptides
  • Back
  • COVID-19 Assays

  • COVID-19 Kits
  • COVID-19 Antibodies
  • COVID-19 Proteins
  • Back
  • Services

  • DNA-based NGS Services
  • Chromatin-based NGS Services
  • qPCR-based Services
  • ELISA-based Services
  • Back
  • DNA-based NGS Services

  • Reduced Representation Bisulfite Sequencing (RRBS)
  • Whole Genome Bisulfite Sequencing (WGBS)
  • Targeted Bisulfite Sequencing
  • Back
  • Chromatin-based NGS Services

  • ChIP Sequencing (Histone Modifications)
  • Back
  • qPCR-based Services

  • Methylation-Specific qPCR (MSP)
  • Back
  • ELISA-based Services

  • Global DNA 5-mC Quantification
  • Global DNA 5-hmC Quantification
  • Global RNA 5-mC Quantification
  • Global RNA m6A Quantification
  • Histone Modification Quantification
  • Back
  • Support

  • Technical Support
  • Quality Assurance
  • Resources
  • Back
  • Technical Support

  • Submit Support Ticket
  • Back
  • Quality Assurance

  • Epigentek Gurantee
  • Risk-Free Testing: Pioneer Program
  • Product Review Program
  • Back
  • Resources

  • Epigenetics Newsletter
  • Intro to Epigenetics
  • What is Epigenetics?
  • Back
  • Corporate

  • Company Information
  • Procurement
  • Communication
  • Back
  • Company Information

  • About Epigentek
  • Press Release
  • Career Opportunities
  • Back
  • Procurement

  • Ordering Information
  • New Lab Startup Program
  • Distributors & Resellers
  • Back
  • Communication

  • Contact Us
  • Customer Feedback Survey
  • Events Calendar
Epigentek Home
Cart (0)
Track
Account
  • Products

    Antibodies

    • DNA Methylation
    • Histone Modification
      • Histone Methylation (Lysine)
      • Histone Methylation (Arginine)
      • Other Histone Methylation
      • Histone Acetylation
      • Histone Deacetylation
      • Other Histone Acetylation
      • Histone Phosphorylation
      • Ubiquitination & SUMOylation
      • Other Histone Antibodies
    • RNA Processing & Modification
    • Chromatin & Transcription
      • Chromatin Remodeling
      • DNA Replication & Transcription
      • Cell Growth
      • Development & Differentiation
    • Cell Structure & Function
      • Cell Cycle
      • DNA Damage & Repair
      • Apoptosis & Cell Death
      • Cellular Structure
      • Trafficking
    • Signal Transduction
      • Cell Surface Receptor & Kinase
      • Intracellular Kinase & Adaptor Protein
      • Phosphatase
      • Secreted Growth Factor
    • Metabolism
      • Glucose Metabolism
      • Lipid Metabolism
      • Protein Metabolism
      • Nucleotide Metabolism
    • Immunology & Inflammation
      • Cell Marker & Receptor
      • Cytokine
      • Other Immunology Antibodies
    • Other Primary Antibodies

    • Secondary Antibodies
    • Tag Antibodies
    • Antibody Panel Packs
      • Histone Modification Panel
      • DNA Methylation Panel

    Research Kits

    • Sample Preparation
      • DNA Preparation
      • RNA Preparation
      • Protein Preparation
      • Chromatin Preparation
    • Next Generation Sequencing
    • DNA Methylation
      • DNA Bisulfite Conversion
      • DNA Methylation Quantification
      • Methylated DNA Immunoprecipitation (meDIP)
      • DNMT & DNA Demethylase Assay
      • Methylated DNA Amplification
    • RNA Methylation
    • Chromatin & Transcription
      • Chromatin Immunoprecipitation
      • ChIP-seq
      • CUT&RUN
      • In Vitro Protein-DNA Interaction
      • Chromatin Accessibility
    • Histone Methylation
      • Histone Methylation Quantification
      • Histone Methytransferase Assay
      • Histone Demethylase Assay
    • Histone Acetylation
      • Histone Acetylation Quantification
      • Histone Acetylase (HAT) Assay
      • Histone Deacetylase (HDAC) Assay
    • Other Histone Modifications
      • Histone Citrullination
      • Histone Phosphorylation
      • SUMOylation
    • DNA Damage & Repair
    • Gene Editing & Silencing

    Proteins & Enzymes

    • DNA Methylation
      • DNA Methylation
      • DNA Demethylation
    • Modified Histones
      • Histone Methylation
      • Histone Demethylation
      • Histone Acetylation
      • Histone Deacetylation
      • Histone Phosphorylation
      • Histone SUMOylation
    • Unmodified Histones
    • Methylated DNA Binding
    • ADP Ribose
    • Chromatin Binding/Transcription
    • DNA Damage & Repair

    Peptides

    • Histone Methylation
    • Histone Acetylation/Deacetylation
    • Histone Phosphorylation

    Instruments

    • Sonication Devices
    • Magnets & Sample Mixers

    COVID-19 Assays

    • COVID-19 Kits
    • COVID-19 Antibodies
    • COVID-19 Proteins
  • Services

    DNA-based NGS Services

    • Reduced Representation Bisulfite Sequencing (RRBS)
    • Whole Genome Bisulfite Sequencing (WGBS)
    • Targeted Bisulfite Sequencing

    Chromatin-based NGS Services

    • ChIP Sequencing (Histone Modifications)

    qPCR-based Services

    • Methylation-Specific qPCR (MSP)

    ELISA-based Services

    • Global DNA 5-mC Quantification
    • Global DNA 5-hmC Quantification
    • Global RNA 5-mC Quantification
    • Global RNA m6A Quantification
    • Histone Modification Quantification
  • Support

    Technical Support

    • Submit Support Ticket
    • Download Datasheet

    Quality Assurance

    • EpigenTek Guarantee
    • Risk-Free Testing: Pioneer Program
    • Product Review Program

    Resources

    • Epigenetics Newsletter
    • Intro to Epigenetics
    • What Is Epigenetics?
  • Corporate

    Company Information

    • About EpigenTek
    • Corporate Sustainability
    • Press Releases
    • Career Opportunities

    Procurement

    • Ordering Information
    • New Lab Startup Program
    • Distributors & Resellers

    Communication

    • Contact Us
    • Customer Feedback Survey
    • Events Calendar
 
EpiGentek Guarantee
   Home  »  Epigenetic Resources  »  Epitherapy: Combating Disease with Epigenetic Drugs 
    Quote Lookup

Epitherapy: Combating Disease with Epigenetic Drugs

A review of the medical industry which is using epigenetic findings to better combat some of the most widespread diseases and ailments

Share:
Epitherapy treatments are being designed with epigenetic principals in mind to help combat some of the most widespread diseases.

The human genome is comprised of some 3 billion bases. Those bases are organized into approximately 20,000 genes. And these genes are controlled by our epigenetics, so-called “on/off” switches that regulate gene expression through a variety of chemical modifications to the DNA and its associated components. Our epigenetic code, not to be confused with our genetic code or DNA sequence, directs normal biological processes such as cell development and specialization. It can determine when and where genes are expressed, aptly repressing or activating expression at specific times (e.g, during stem cell differentiation) and in specific cell types (e.g., insulin expression localized to pancreatic islet β-cells)[1].

In addition to being heritable, the epigenetic landscape of our bodies can be influenced by non-inborn factors like environmental cues and lifestyle habits (food, sleep, exercise). Aberrant changes by these or other factors to our epigenome may contribute to or cause disease. Inflammatory, metabolic, infectious, cardiovascular, and neurological disorders, as well as cancers, all display epigenetic abnormalities as part of their pathologies. Interestingly, this epigenomic dysregulation is reversible, and epigenetic modifications have been pursued as suitable biomarkers for pharmaceutical treatments and epigenetic drug discovery research.

According to recent market intelligence data, the global epigenomic market, valued at $5.28 billion in 2017, will be at $16.3 billion by 2026. FDA-approved epigenetic drugs currently on the market are categorized into two classes, based on their mechanism of action. The first class is comprised of the histone deacetylase (HDAC) inhibitors[2], constituting the bulk of the epigenetic drug market. HDACs are a class of enzymes that remove acetyl groups on lysine residues in the N-terminal tail and on the nucleosome-core surface of histones. Deacetylated histones compact chromatin structure and thereby reduce gene transcription levels. Deviations from normal HDAC activity can induce irregular transcription of genes regulating cell proliferation and apoptosis, promoting tumor growth and metastasis. Marketed HDAC inhibitors include Novartis’s Farydak (panobinostat) for multiple myeloma, Celgene’s Istodax (romidepsin) and Merck’s Zolinza (vorinostat) for cutaneous T-cell lymphoma, and TopoTarget’s Beleodaq (belinostat) for peripheral T-cell lymphoma.

To conduct your own experiment to measure the activity or inhibition of total histone deacetylase (HDAC) in a convenient, sensitive and fast assay, we recommend the Epigenase HDAC Activity/Inhibition Direct Assay Kit (Colorimetric). This kit takes just 3.5 hours to complete thanks to its versatile strip-well microplate format and is sensitive enough to detect activity from as low as 0.5 ng of purified HDAC enzyme.

Inhibitors of DNA methyltransferase (DNMT) make up the second class of epigenetic drugs, which include Otsuka Pharmaceutical’s Dacogen (decitabine) and Celgene’s Vidaza (azacytidine) for myelodysplastic syndrome. DNMTs serve as DNA methylating agents, covalently adding methyl groups to the 5-carbon position of cytosines that project into the major grooves of DNA and inhibit transcription. Abnormal DNA methylation associated with increased DNMT expression or activity has been found in many different diseases, especially in cancer. For example, transcriptional silencing of tumor suppressor genes via promoter region hypermethylation is known to occur during oncogenesis[3]. Inhibition of DNMTs may lead to demethylation and expression of silenced genes.

Aside from HDAC and DNMT inhibitors, drugs targeting other epigenetic modifiers are actively being pushed through the biopharmaceutical pipeline and in various clinical trial stages. These targets include histone methyltransferases (HMTs) like EZH2 and DOT1L; HMT binding partner interactions like that between menin and the histone methyltransferase MLL; histone demethylases like LSD1; histone ubiquitination-mediating proteins like PRC1; and BETs, proteins that interact with acetylated histones[4]. Interest in epigenetic therapy is expanding, as is the growth of biotech startups focused on identifying new epigenetic targets and the next “epi-pharmaceutical” blockbuster. Flagship Pioneering’s Omega Therapeutics, which was recently launched in September, has made headlines lately for its in silico approach to identifying potential targets using computational biology. Additionally, the incorporation of epigenetic drugs in combination therapies to improve the activity of other medicinal agents rendered ineffective by drug resistance is an emerging field with great potential.

A major setback for these drugs is their lack of specificity. Off-target issues such as global hypomethylation and non-histone protein modification, along with their accompanying side effects, are a concern. Due to the complexity of the epigenome, the identification of disease-specific epigenetic biomarkers is paramount to developing novel drugs with precise targets, thereby lowering doses, minimizing toxicity, and increasing efficacy. Innovations in nanotechnology and single-cell sequencing will undoubtedly facilitate advancements in personalized-targeted therapy, providing customized treatment tailored to an individual’s unique epigenome. EpiGentek is continually striving to improve upon the speed, sensitivity, accuracy, and simplicity by which these biomarkers are assessed and quantified. EpiGentek’s next generation MethylFlash and EpiQuik technologies provide for rapid and direct measurements of the most commonly studied epigenetic modifications, including DNA methylation, RNA methylation, histone modifications, and protein-DNA interactions. Although epigenetic drugs at present are primarily geared toward treating patients with cancer, other diseases like diabetes, rheumatoid arthritis, Alzheimer’s disease, schizophrenia, and atherosclerosis, to name a few, have been linked to epigenetic anomalies and present new opportunities for therapeutic intervention.




References:

  1. Olsen JA, Kenna LA, Spelios MG, Hessner MJ, Akirav EM. Circulating differentially methylated amylin DNA as a biomarker of β-cell loss in type 1 diabetes. PLoS One 2016;11:e0152662
  2. Katarzyna R, Lucyna B. Epigenetic therapies in patients with solid tumors: focus on monotherapy with deoxyribonucleic acid methyltransferase inhibitors and histone deacetylase inhibitors. J Can Res Ther 2019;15:961-70
  3. Subramaniam D, Thombre R, Dhar A, Anant S. DNA methyltransferases: a novel target for prevention and therapy. Front Oncol 2014;4:80
  4. Ye F, Huang J, Wang H, Luo C, Zhao K. Targeting epigenetic machinery: Emerging novel allosteric inhibitors. Pharmacol Ther 2019;107406

Epigenetic Resources
  • Antibodies
  • DNA Methylation
  • RNA Methylation
  • Chromatin Remodeling
  • Histone Modifications
  • Gene Editing
  • Miscellaneous
BOGO-Conjugate Abs
Recent Resource Bulletins
  • Therapeutic Potential of m6A RNA Methylation
  • How CUT&RUN Helps Improve Methylated RNA Immunoprecipitation
  • Accessing Histone PTMs: Insights Into the Methods Used for Their Assessment
Featured Areas of Study
DNA, Protein, & Chromatin Preparation
DNA Methylation & Demethylation Analysis
Chromatin Immunoprecipitation
Histone Methylation & Demethylation
Histone Acetylation & Deacetylation
Gene Expression & Silencing
DNA Damage & Repair
Histone Phosphorylation
SUMOylation
Next-Generation Sequencing
Products & Services
Ordering Information & Return Policy
Epigenetic Services
Discounts & Promotions
Rewards Program
Product Reviews
New Lab Startup Program
Risk-Free Testing: Pioneer Program

Support
Download Datasheets
Epigentek Guarantee
Technical Support
Corporate
About Epigentek
Press Releases
Product Newsletter
Events Calendar
Distributors & Resellers
EpigenCare
Career Opportunities
Contact Us

Stay Informed



Terms & Conditions | Privacy Policy | Site Map
Copyright © 2019 EpiGentek Group Inc. All rights reserved.
  • Stay Informed:
Terms & Conditions | Privacy Policy Copyright © EpiGentek